Thanks for the kind words. I enjoyed doing the wri

Thanks for the kind words. I enjoyed doing the write up and sharing my opinions, bullish as they may be. My goal was to lay out the story of Kevetrin in a very simple and digestible way, there is really nothing "new" here for anyone who has continued to follow the company closely. There is a whole big world of investors out there, and I do believe that in time there will be many newcomers attracted to the company that may not normally swim in the murky waters of the biotech sector. It's my humble hope that this would be an easy to understand read for these folks, and potentially be a starting point for them to dig deeper and draw their own conclusions. I don't expect that everyone be as bullish as I am about the company, but I make no excuses for my stance as I believe in the science and the management here.